Radioiodine treatment of multinodular non-toxic goitre
- PMID: 8401123
- PMCID: PMC1678858
- DOI: 10.1136/bmj.307.6908.828
Radioiodine treatment of multinodular non-toxic goitre
Abstract
Objective: To investigate the long term effect of radioactive iodine on thyroid function and size in patients with non-toxic multinodular goitre.
Design: Consecutive patients with multinodular non-toxic goitre selected for radioactive iodine treatment and followed for a minimum of 12 months (median 48 months) after an intended dose of 3.7 MBq/g thyroid tissue corrected to a 100% uptake of iodine-131 in 24 hours.
Patients: 69 patients with a growing multinodular non-toxic goitre causing local compression symptoms or cosmetic inconveniences. The treatment was chosen because of a high operative risk, previous thyroidectomy, or refusal to be operated on.
Main outcome measurements: Standard thyroid function variables and ultrasonically determined thyroid volume before treatment as well as 1, 2, 3, 6, and 12 months after treatment and then once a year.
Results: 56 patients were treated with a single dose of 131I, 12 with two doses, and one with four doses. In 45 patients treated with one dose and remaining euthyroid the median thyroid volume was reduced from 73 (interquartile range 50-106) ml to 29 (23-48) ml at 24 months in the 39 patients in whom this was measured during follow up. The median reduction was 40 (22-48) ml (60% reduction, p < 0.0001), half of which occurred within three months. Patients treated with two doses as well as those developing hypothyroidism and hyperthyroidism had a significant reduction in thyroid volume. Eleven patients developed hypothyroidism (cumulative five year risk 22%, 95% confidence interval 4.8% to 38.4%). Side effects were few: three cases of hyperthyroidism and two cases of radiation thyroiditis. Only one patient was dissatisfied with the result; she was referred for operation six months after treatment.
Conclusions: A substantial reduction in thyroid volume accompanied by a low incidence of hypothyroidism and few side effects makes the use of radioactive iodine an attractive alternative to surgery in selected cases of non-toxic multinodular goitre.
Similar articles
-
[Long-term effect of 131I therapy of multinodular non-toxic goiter].Ugeskr Laeger. 1994 Sep 26;156(39):5699-703. Ugeskr Laeger. 1994. PMID: 7985257 Danish.
-
Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.Clin Endocrinol (Oxf). 1999 Jun;50(6):783-9. doi: 10.1046/j.1365-2265.1999.00734.x. Clin Endocrinol (Oxf). 1999. PMID: 10468951
-
Recombinant human thyrotropin stimulation prior to 131I therapy in toxic multinodular goitre with low radioactive iodine uptake.Rev Esp Med Nucl Imagen Mol. 2017 Jan-Feb;36(1):7-12. doi: 10.1016/j.remn.2016.05.009. Epub 2016 Jul 12. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 27422154 Clinical Trial. English, Spanish.
-
Radioiodine - an attractive alternative to surgery in large non-toxic multinodular goitres.Nucl Med Rev Cent East Eur. 2009;12(1):23-9. Nucl Med Rev Cent East Eur. 2009. PMID: 19554518 Review.
-
Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons.Minerva Endocrinol. 2010 Sep;35(3):161-71. Minerva Endocrinol. 2010. PMID: 20938419 Review.
Cited by
-
Quantitative Iodine-123 single-photon emission computed tomography/computed tomography for Iodine-131 therapy of an autonomously functioning thyroid nodule.Eur J Hybrid Imaging. 2023 Feb 20;7(1):4. doi: 10.1186/s41824-022-00159-w. Eur J Hybrid Imaging. 2023. PMID: 36807846 Free PMC article.
-
Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre.Cochrane Database Syst Rev. 2021 Dec 28;12(12):CD010622. doi: 10.1002/14651858.CD010622.pub2. Cochrane Database Syst Rev. 2021. PMID: 34961921 Free PMC article.
-
An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.Endocrine. 2008 Apr;33(2):109-17. doi: 10.1007/s12020-008-9077-7. Epub 2008 May 20. Endocrine. 2008. PMID: 18491237 Review.
-
Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium.Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1081-8. doi: 10.1007/s00259-005-1818-8. Epub 2005 May 4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15871016 Clinical Trial.
-
Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.Endocrine. 2011 Dec;40(3):344-53. doi: 10.1007/s12020-011-9542-6. Epub 2011 Oct 5. Endocrine. 2011. PMID: 21971931 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources